Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 10 studies | 28% ± 11% | |
| smooth muscle cell | 5 studies | 20% ± 6% | |
| pericyte | 5 studies | 28% ± 7% | |
| retinal cone cell | 4 studies | 27% ± 8% | |
| retinal rod cell | 4 studies | 19% ± 3% | |
| adipocyte | 4 studies | 22% ± 3% | |
| astrocyte | 4 studies | 26% ± 7% | |
| endothelial cell of vascular tree | 4 studies | 36% ± 4% | |
| retinal pigment epithelial cell | 3 studies | 26% ± 7% | |
| fibroblast | 3 studies | 24% ± 5% | |
| ciliated cell | 3 studies | 31% ± 17% | |
| basal cell | 3 studies | 20% ± 2% | |
| hepatocyte | 3 studies | 23% ± 8% | |
| muscle cell | 3 studies | 24% ± 8% | |
| non-classical monocyte | 3 studies | 28% ± 7% | |
| vein endothelial cell | 3 studies | 24% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 26% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 2148.81 | 962 / 966 | 99% | 20.41 | 520 / 527 |
| prostate | 100% | 2016.51 | 244 / 245 | 98% | 27.09 | 494 / 502 |
| esophagus | 100% | 2132.68 | 1442 / 1445 | 98% | 20.94 | 179 / 183 |
| lung | 100% | 3673.16 | 577 / 578 | 97% | 17.32 | 1126 / 1155 |
| liver | 100% | 8377.04 | 226 / 226 | 96% | 42.74 | 391 / 406 |
| breast | 100% | 3179.61 | 459 / 459 | 96% | 18.48 | 1072 / 1118 |
| stomach | 97% | 2339.06 | 347 / 359 | 98% | 17.57 | 281 / 286 |
| skin | 99% | 2308.61 | 1796 / 1809 | 96% | 18.16 | 451 / 472 |
| uterus | 100% | 3987.28 | 170 / 170 | 95% | 18.89 | 435 / 459 |
| thymus | 100% | 2693.61 | 652 / 653 | 94% | 17.33 | 571 / 605 |
| pancreas | 95% | 4080.47 | 311 / 328 | 98% | 27.34 | 175 / 178 |
| brain | 93% | 1961.91 | 2467 / 2642 | 100% | 33.89 | 702 / 705 |
| bladder | 100% | 2284.81 | 21 / 21 | 89% | 13.67 | 448 / 504 |
| adrenal gland | 100% | 2506.52 | 258 / 258 | 89% | 21.48 | 204 / 230 |
| kidney | 100% | 3058.91 | 89 / 89 | 81% | 10.35 | 733 / 901 |
| ovary | 100% | 3287.97 | 180 / 180 | 79% | 9.17 | 339 / 430 |
| spleen | 100% | 1930.72 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 4434.86 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 2014.85 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 6330.38 | 797 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 35.50 | 79 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 21.92 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 10.51 | 26 / 29 |
| heart | 68% | 821.20 | 587 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 58% | 668.46 | 537 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0015866 | Biological process | ADP transport |
| GO_0043010 | Biological process | camera-type eye development |
| GO_0035264 | Biological process | multicellular organism growth |
| GO_0070588 | Biological process | calcium ion transmembrane transport |
| GO_0032094 | Biological process | response to food |
| GO_0046034 | Biological process | ATP metabolic process |
| GO_0045333 | Biological process | cellular respiration |
| GO_0014823 | Biological process | response to activity |
| GO_0060612 | Biological process | adipose tissue development |
| GO_0002021 | Biological process | response to dietary excess |
| GO_0015867 | Biological process | ATP transport |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0140987 | Molecular function | ATP:phosphate antiporter activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005347 | Molecular function | ATP transmembrane transporter activity |
| Gene name | SLC25A25 |
| Protein name | Mitochondrial adenyl nucleotide antiporter SLC25A25 (Mitochondrial ATP-Mg/Pi carrier protein 3) (Mitochondrial Ca(2+)-dependent solute carrier protein 3) (Short calcium-binding mitochondrial carrier protein 2) (SCaMC-2) (Solute carrier family 25 member 25) Solute carrier family 25 member 25 Alternative protein SLC25A25 |
| Synonyms | UNQ549/PRO1106 KIAA1896 MCSC3 APC3 SCAMC2 |
| Description | FUNCTION: Electroneutral antiporter that most probably mediates the transport of adenyl nucleotides through the inner mitochondrial membrane. Originally identified as an ATP-magnesium/inorganic phosphate antiporter, it could have a broader specificity for adenyl nucleotides. By regulating the mitochondrial matrix adenyl nucleotide pool could adapt to changing cellular energetic demands and indirectly regulate adenyl nucleotide-dependent metabolic pathways. . |
| Accessions | ENST00000373069.10 [Q6KCM7-3] ENST00000472769.5 ENST00000373066.9 [Q6KCM7-5] Q6KCM7 ENST00000432073.6 [Q6KCM7-4] A0A804HLB0 H7C4Z4 ENST00000466983.1 ENST00000373064.9 [Q6KCM7-1] ENST00000683206.1 F8WEY9 ENST00000682371.1 ENST00000373068.6 [Q6KCM7-2] A0A804HI56 L0R8F1 |